Abstract
Properties that are contaminated with methamphetamine (meth) are sometimes remediated in accordance with state health regulations which contain a health standard for the surface concentration that must be achieved after remedial work is complete. Nearly all states use the same criterion for all parts of the property, even though the extent of dermal and ingestion exposure is related to the occupancy time. For areas such as attics that experience low occupancy time, the high costs of remediation are not justified by exposure considerations. One challenge in defining alternative standards for different space types was the lack of risk-based metrics to use. The analysis reported here provides a framework for determining the exposure differentials as well as the potential cost savings that would occur if alternate standards are set. Low-occupancy space types such as attics, moderate-occupancy space types such as exterior hallways, and HVAC system were evaluated with calculations of frequency of contamination, remediations costs, and incremental exposure/dose to occupants under a broad range of potential standards. Raising very conservative standards set by some states would reduce the average cost to remediate a contaminated house from $18,700 to $15,000 or even $12,500. Substantial remediation cost reductions are likely to be achieved if health standards are based on occupancy time. If all recommended alternate standards are implemented, a further 40-50% cost reduction is possible. These alternate standards still allow the exposure to be within the recommended dose levels, which suggests that these low occupancy spaces are being over remediated. Currently, the high cost of remediation is a burden on thousands of property owners who remediate meth-contaminated property each year, but are also a deterrent to testing suspect properties, resulting in large numbers of contaminated properties remaining occupied.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.